EUVIMEDEUVIMED entdecken
Multizentrische Studie

Treatment with Sofosbuvir/Velpatasvir of the most difficult to cure HCV-infected population

Robert Flisiak iD, Dorota Zarębska-Michaluk, Hanna Berak, Magdalena Tudrujek-Zdunek, Beata Lorenc, Krystyna Dobrowolska, Justyna Janocha-Litwin, Włodzimierz Mazur, Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz

Polish Archives of Internal Medicine · 2024

DOI: 10.20452/pamw.16644 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Polish Archives of Internal Medicine, 2024. Verfasst von Robert Flisiak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Białystok, Poland. robert.flisiak1@gmail.com. Hauptthemen laut MEDLINE: Sofosbuvir, Hepatitis C, Benzimidazoles, Benzopyrans. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SofosbuvirHepatitis CBenzimidazolesBenzopyransCarbamatesHeterocyclic Compounds, 4 or More RingsMaleHumansHepacivirusAntiviral AgentsRetrospective StudiesRibavirinTreatment OutcomeLiver CirrhosisObesity

Substanzen

SofosbuvirvelpatasvirAntiviral AgentsRibavirinBenzimidazolesBenzopyransCarbamatesHeterocyclic Compounds, 4 or More Rings

Autor:innen und Institutionen

  • Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Białystok, Poland. robert.flisiak1@gmail.com
  • Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland
  • Hospital for Infectious Diseases in Warsaw, Warsaw, Poland
  • Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland
  • Pomeranian Center of Infectious Diseases, Gdańsk, Poland
  • Collegium Medicum, Jan Kochanowski University, Kielce, Poland

ORCID-Profile: Robert Flisiak

Zitieren

APA

Flisiak, R., Zarębska-Michaluk, D., Berak, H., Tudrujek-Zdunek, M., Lorenc, B., Dobrowolska, K., Janocha-Litwin, J., Mazur, W., Parfieniuk-Kowerda, A., & Jaroszewicz, J. (2024). Treatment with Sofosbuvir/Velpatasvir of the most difficult to cure HCV-infected population. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.16644

Vancouver

Flisiak R, Zarębska-Michaluk D, Berak H, Tudrujek-Zdunek M, Lorenc B, Dobrowolska K, et al. Treatment with Sofosbuvir/Velpatasvir of the most difficult to cure HCV-infected population. Polish Archives of Internal Medicine. 2024. doi:10.20452/pamw.16644

BibTeX
@article{Flisiak2024,
  author = {Flisiak, Robert and Zarębska-Michaluk, Dorota and Berak, Hanna and Tudrujek-Zdunek, Magdalena and Lorenc, Beata and Dobrowolska, Krystyna and Janocha-Litwin, Justyna and Mazur, Włodzimierz and Parfieniuk-Kowerda, Anna and Jaroszewicz, Jerzy},
  title = {Treatment with Sofosbuvir/Velpatasvir of the most difficult to cure HCV-infected population},
  journal = {Polish Archives of Internal Medicine},
  year = {2024},
  doi = {10.20452/pamw.16644}
}
Kostenlos starten →